Concepedia

Roselyne Castonguay

RC

22

Publications

1.3K

Citations

18

H-Index

2001

Active since

Affiliations

Acceleron Pharma (United States)(Current)

Université de Montréal

Harvard University

University of Cincinnati

TScan Therapeutics (United States)

Roselyne Castonguay is an author at Acceleron Pharma (United States) specializing in medicine, biochemistry, and cell signaling.

Top concepts

Publications per year

2001–2025

22

Publications

22

Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth

Roselyne Castonguay, Eric D. Werner, Robert G. Matthews et al. · Journal of Biological Chemistry · 2011 · 219 citations · Full text

, , +17

ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth

Dianne Mitchell, Eileen G. Pobre, Aaron W. Mulivor et al. · Molecular Cancer Therapeutics · 2010 · 151 citations · Full text

Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB

Dianne Sako, Asya V. Grinberg, June Liu et al. · Journal of Biological Chemistry · 2010 · 149 citations · Full text

, , +20

Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension

Sachindra Raj Joshi, Jun Liu, Troy Bloom et al. · Scientific Reports · 2022 · 87 citations · Full text

Stereospecificity of Ketoreductase Domains of the 6-Deoxyerythronolide B Synthase

Roselyne Castonguay, Weiguo He, Alice Y. Chen et al. · Journal of the American Chemical Society · 2007 · 85 citations · Full text

Rows per page

1–5 of 22